Terapia Ranbaxy : Latest News on Terapia Ranbaxy , Terapia Ranbaxy Updates, Terapia Ranbaxy Videos, Photos, Wiki, Topic

Share >

Share on Tumblr

Terapia Ranbaxy

News »
latest by relevance

Ranbaxy to market Daiichi Sankyos products in Mexico

Oct 06, 2009 at 08:50 | Source: Business Line

Ranbaxy Laboratories Ltd has said that it would start marketing Daiichi Sankyos products in Mexico through a recently created marketing division. This is the first time in Latin America that Daiichi Sankyo and Ranbaxy are leveraging mutual synergies post the acquisition of the Indian drug maker.

Ranbaxy: In top 5 pharma club by 2012?

Aug 06, 2007 at 15:14

Indias largest pharmaceutical company, Ranbaxy is a generics firm. Falling prices and increased competition have vaporized already slim profit margins in the past few years. Here is what they are doing about it....

Ranbaxy to invest $20 m in Terapia

Apr 21, 2007 at 09:10

Ranbaxy will be investing $20 million (Rs 83 crore) in its Romanian facility, Terapia in the next two years.

Terapia Ranbaxy receives GMP Certificate renewal

Apr 03, 2007 at 18:37

Terapia Ranbaxy receives GMP Certificate renewal from National Agency of Medicine for Bucharest site

Terapia Ranbaxy gets mrkt authorisations for 20 products

Mar 07, 2007 at 14:21

Terapia Ranbaxy gets market authorisations for 20 new products

Terapia-Ranbaxy receives EU compliance for mfg & import

Feb 22, 2007 at 14:38

Terapia -Ranbaxy receives EU compliance for manufacturing and import authorization

Videos »

Ranbaxy: In top 5 pharma club by 2012?

Not eyeing any acquisition in France: Ranbaxy

Ranbaxy's revenue growth to be led by Terapia acquisition

Photos »

News across the web »

Sensex closes up 112 pts, Reliance Inds slumps ahead of results

3:30 pm After starting off on a flat note, markets closed the day on on positive note as the Sensex closed up 112 points to 17528 while the Nifty was up 32 to 5332. Autos were in news today after the...

Apr 23, 2012 at 23:37 | Source: FirstPost

Ranbaxy to sell Daiichi’s hypertension drug in Romania

Drug firm Ranbaxy Laboratories and its parent Daiichi Sankyo today said they will launch Sevikar, a hypertension drug, in Romania under their collaborative business strategy.Terapia Ranbaxy, a subsid...

Apr 19, 2012 at 22:26 | Source: The Hindu BusinessLine

Ranbaxy to sell Daiichi’s anti-hypertension drug in Romania

New Delhi: Drug firm Ranbaxy Laboratories and its parent Daiichi Sankyo today said they will launch Sevikar, a hypertension drug, in Romania under their collaborative business strategy. Terapia Ranba...

Apr 19, 2012 at 15:31 | Source: FirstPost

Ranbaxy to sell Daiichi’s anti-hypertension drug in Romania

New Delhi, April 19: Drug firm Ranbaxy Laboratories and its parent Daiichi Sankyo today said they will launch Sevikar, a hypertension drug, in Romania under their collaborative business strategy.Tera...

Apr 19, 2012 at 15:31 | Source: The Hindu BusinessLine

Live: Sensex up 100 pts as Europe markets rebound

1:30 The Sensex has jumped almost 100 points to 17504 while the Nifty is up 36 points to 5337 after European stock markets rebounded from prior-day losses as markets awaited an auction of Spanish d...

Apr 19, 2012 at 13:51 | Source: FirstPost

Interact & exchange stock tips & market info »

Firstpost

Platinum Member

230 Followers

Ranbaxy Labs

Source:FirstPost - New Delhi: Drug firm Ranbaxy Laboratories and its ...

5.12 PM Apr 19th

Web Messenger

Platinum Member

107979 Followers

Ranbaxy Labs

Source:The Hindu BusinessLine - New Delhi, April 19: Drug firm Ranbax...

5.10 PM Apr 19th

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol

STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

MUTUAL FUNDS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.